Panacea Biotec Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	643.7	821.25	471.74	398.52	503.5
Short-Term Investments	100.3	440.91	638.99	1,598	4,963
Trading Asset Securities	-	31.53	403.62	134.16	50.01
Cash & Short-Term Investments	744	1,294	1,514	2,130	5,516
Cash Growth	-42.49%	-14.57%	-28.92%	-61.38%	505.00%
Accounts Receivable	735.2	725.57	574.19	600.92	816.56
Other Receivables	-	11.58	10.57	12.02	10.58
Receivables	754.6	762.82	618.08	628.74	841.54
Inventory	1,928	2,137	1,779	2,021	2,127
Prepaid Expenses	-	71.08	60.63	52.2	53.49
Other Current Assets	1,704	1,187	882.26	850.84	1,367
Total Current Assets	5,130	5,452	4,855	5,683	9,906
Property, Plant & Equipment	6,532	6,369	6,348	6,163	6,255
Long-Term Investments	0.7	1.17	1.72	1.74	803.91
Other Intangible Assets	508.9	360.91	276.32	153.3	132.36
Long-Term Deferred Tax Assets	-	-	-	-	237.51
Long-Term Deferred Charges	-	61.71	83.66	106.11	5.88
Other Long-Term Assets	449.3	652.84	843.43	600.99	248.48
Total Assets	12,622	12,897	12,408	12,712	17,589
Accounts Payable	1,896	2,258	1,456	1,773	2,347
Accrued Expenses	-	369.66	439.6	361.43	404.63
Short-Term Debt	-	-	-	0.55	-
Current Portion of Long-Term Debt	-	-	-	-	0.52
Current Income Taxes Payable	20.3	0.08	1.35	5.6	0.85
Current Unearned Revenue	-	17.69	171.03	196.62	-
Other Current Liabilities	1,571	1,025	1,022	980.88	5,010
Total Current Liabilities	3,487	3,670	3,090	3,318	7,764
Long-Term Debt	236.6	222.06	209.94	201.64	341.03
Long-Term Unearned Revenue	-	108.52	218.46	321.39	455.88
Pension & Post-Retirement Benefits	-	191.06	164.51	134.25	144.26
Long-Term Deferred Tax Liabilities	231.4	232.82	225.45	203.71	-
Other Long-Term Liabilities	378.1	166.91	117.78	131.22	147.3
Total Liabilities	4,333	4,591	4,026	4,311	8,852
Common Stock	61.3	61.25	61.25	61.25	61.25
Additional Paid-In Capital	-	919.4	919.4	919.4	919.4
Retained Earnings	-	8,594	8,678	8,694	9,041
Comprehensive Income & Other	8,287	-1,443	-1,455	-1,455	-1,472
Total Common Equity	8,348	8,131	8,204	8,219	8,550
Minority Interest	-59.6	-41.7	-38.21	-34.89	-29.81
Shareholders' Equity	8,289	8,306	8,382	8,401	8,737
Total Liabilities & Equity	12,622	12,897	12,408	12,712	17,589
Total Debt	236.6	222.06	209.94	202.19	341.55
Net Cash (Debt)	507.4	1,072	1,304	1,928	5,175
Net Cash Growth	-52.65%	-17.85%	-32.35%	-62.74%	-
Net Cash Per Share	8.31	17.50	21.30	31.48	84.48
Filing Date Shares Outstanding	65	61.25	61.25	61.25	61.25
Total Common Shares Outstanding	65	61.25	61.25	61.25	61.25
Working Capital	1,644	1,782	1,765	2,365	2,142
Book Value Per Share	128.44	132.75	133.94	134.19	139.59
Tangible Book Value	7,840	7,770	7,928	8,066	8,417
Tangible Book Value Per Share	120.61	126.86	129.43	131.69	137.43
Land	-	2,068	2,059	2,059	2,027
Buildings	-	3,155	3,196	3,333	3,333
Machinery	-	6,624	6,442	6,509	6,512
Construction In Progress	-	935.13	747.15	280.07	49.12